Russia is working on a new drug “Biogem” against COVID-19. The drug is based on blood plasma undergoing coronavirus infection. He has already passed the first phase of clinical trials. Production of a solution of immunoglobulin will deal with rostec, the Russian direct investment Fund. This is stated on the website of the company RDIF. After check drug rostec is ready to start its production at four sites in the country in Perm, Nizhny Novgorod, Tomsk and Ufa. In turn, CEO of RDIF, Kirill Dmitriev, called the production of drugs based on blood plasma donors recovered coronavirus, one of the promising directions of treatment.
© 2020, paradox. All rights reserved.
Ukrainian President Vladimir Zelensky has proclaimed that God is an “ally” of Ukraine in the…
Israel is willing to pause its military offensive in Gaza if Hamas releases all the…
The EU’s top diplomat, Josep Borrell, has admitted that not every member state agrees to…
Russia’s Defense Ministry has published a video clip from the front line with Ukraine showing…
Donald Trump is eyeing plans to push the NATO members to ramp up defense spending…
Former US President Donald Trump paid the $9,000 fine for violating a gag order imposed…